Biopharmaceutical/Medical Devices - Drug Delivery Systems
Strategic Profile
Formed in August 2022 through a merger of Second Sight Medical Products and Nano Precision Medical, Vivani inherited neurostimulation assets and NPM's NanoPortal drug implant technology, with a strategic pivot to prioritize the Biopharm pipeline. The company announced the spin-off of Cortigent, its wholly-owned subsidiary developing brain implant devices with cutting-edge neuromodulation technology.
Cyborg Score Rationale
The anticipated top-line data from LIBERATE-1 in mid-2025 represents a key catalyst for platform validation, while significant risks remain concerning future financing needs and clinical trial outcomes despite the compelling long-term opportunity. The company's clinical-stage status and capital requirements present execution risk.
Top Insights
Lead drug implant candidates are designed to improve medication adherence and deliver smooth consistent therapeutic levels of GLP-1 for six months or longer with a single administration.
NPM-115 and NPM-119 are miniature, six-month GLP-1 implants under development for obesity/chronic weight management and type 2 diabetes treatment, respectively.
Cortigent subsidiary spin-off was set for completion with expected Nasdaq trading under ticker CRGT, allowing focused development of brain implant devices.
Recent equity financings of approximately $8.25 million in March 2025 and $3.0 million in May 2025 extended cash runway into Q2 2026.
Named Competitors
Ozempic/Wegovy — Weekly injectable GLP-1 agonist for diabetes and weight management
Trulicity — Weekly injectable GLP-1 agonist for diabetes
Various long-acting GLP-1 formulations — Monthly or quarterly injectable alternatives
Recent Developments
(September 2025) Announced record date for Cortigent neuromodulation subsidiary spin-off with expected NASDAQ listing
(May 2025) Completed $3.0 million equity financing to support R&D and clinical activities
(March 2025) Raised $8.25 million in equity financing to extend cash runway
Open the full interactive Vivani Medical, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.